Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

American Society Of Clinical Oncology (ASCO) 2017 Annual Meeting is organized by American Society Of Clinical Oncology (ASCO) and was held on June 2 -6, 2016 at McCormick Place in Chicago. The conference program offers informative educational and scientific sessions on the latest cancer care treatments.

ASCO 2017

02–06 June 2017 | Chicago, USA

ASCO 2017

02–06 June 2017 | Chicago, USA
American Society Of Clinical Oncology (ASCO) 2017 Annual Meeting is organized by American Society Of Clinical Oncology (ASCO) and was held on June 2 -6, 2016 at McCormick Place in Chicago. The conference program offers informative educational and scientific sessions on the latest cancer care treatments.
Is the current dose of pembrolizumab approved for treating lung cancer too high? 2:09
Is the current dose of pembrolizumab approved for treating lung cancer too high?
Daniel Goldstein • 2 Jun 2017
Daratumumab: a necessary addition to the standard of care for MM? 1:04
Daratumumab: a necessary addition to the standard of care for MM?
Katja J. Weisel • 2 Jun 2017
Palbociclib: single-agent or in combination for the treatment of breast cancer 6:47
Palbociclib: single-agent or in combination for the treatment of breast cancer
Luca Malorni • 2 Jun 2017
Advancements in treating brain metastases in cancer 2:30
Advancements in treating brain metastases in cancer
Manmeet Ahluwalia • 2 Jun 2017
Can nivolimumab aid in preventing gastrointestinal cancer progression? 1:56
Can nivolimumab aid in preventing gastrointestinal cancer progression?
Ronan Joseph Kelly • 3 Aug 2017
EBV and MSI – subsets of gastric cancer that respond better to therapy 2:30
EBV and MSI – subsets of gastric cancer that respond better to therapy
Ronan Joseph Kelly • 2 Jun 2017
Biosimilars: The future of treating breast cancer 1:26
Biosimilars: The future of treating breast cancer
Justin Stebbing • 2 Jun 2017
Educating patients about their cancer 1:04
Educating patients about their cancer
Howard Burris • 20 Jun 2017
The physician’s role in prescribing biosimilars to patients 1:02
The physician’s role in prescribing biosimilars to patients
Justin Stebbing • 2 Jun 2017
mHealth: a new perspective for healthcare 2:08
mHealth: a new perspective for healthcare
Adam Dicker • 12 Jun 2017
How to ensure optimal patient engagment with mobile apps 1:39
How to ensure optimal patient engagment with mobile apps
Adam Dicker • 12 Jun 2017
Improving patient outcomes using mHealth technologies 1:53
Improving patient outcomes using mHealth technologies
Heather Jim • 13 Jun 2017
What does the future hold for mHealth? 1:28
What does the future hold for mHealth?
Heather Jim • 13 Jun 2017
The importance of knowing the molecular profile of a patient’s tumor 1:22
The importance of knowing the molecular profile of a patient’s tumor
Howard Burris • 2 Jun 2017
The impact of TRK inhibitor LOXO-101 (larotrectinib) on patients with TRK fusion cancers 0:52
The impact of TRK inhibitor LOXO-101 (larotrectinib) on patients with TRK fusion cancers
Howard Burris • 2 Jun 2017
Results of the combined inhibition of IDO1 and PD-L1 in locally advanced or metastatic solid tumors 1:09
Results of the combined inhibition of IDO1 and PD-L1 in locally advanced or metastatic solid tumors
Howard Burris • 2 Jun 2017
The content of VJOncology is intended for healthcare professionals